Inventor
SAH DINAH WEN-YEE
US41 patents
⚠️ This page may combine multiple inventors who share the name “SAH DINAH WEN-YEE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VOYAGER THERAPEUTICS INC
19 patentsUS10597660B2Mar 24, 2020
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC11 citations93
US10584337B2Mar 10, 2020
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC15 citations91
US11603542B2Mar 14, 2023
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC7 citations85
US11193129B2Dec 7, 2021
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC8 citations83
US10920227B2Feb 16, 2021
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC8 citations83
US11434502B2Sep 6, 2022
Treatment of amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC5 citations82
US11752181B2Sep 12, 2023
Compositions and methods of treating Huntington's disease
VOYAGER THERAPEUTICS INC4 citations73
US11542506B2Jan 3, 2023
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC3 citations72
US11512327B2Nov 29, 2022
Compositions and methods for delivery of AAV
VOYAGER THERAPEUTICS INC3 citations71
US11951121B2Apr 9, 2024
Compositions and methods for treating Huntington's disease
VOYAGER THERAPEUTICS INC0 citations62
US12123002B2Oct 22, 2024
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC0 citations61
US12305189B2May 20, 2025
Compositions and methods for delivery of AAV
VOYAGER THERAPEUTICS INC0 citations60
US12281321B2Apr 22, 2025
Frataxin expression constructs having engineered promoters and methods of use thereof
VOYAGER THERAPEUTICS INC0 citations59
US12084659B2Sep 10, 2024
Modulatory polynucleotides
VOYAGER THERAPEUTICS INC0 citations59
US12146150B2Nov 19, 2024
Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
VOYAGER THERAPEUTICS INC0 citations57
US12116589B2Oct 15, 2024
Treatment of amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC0 citations57
US11931375B2Mar 19, 2024
Treatment of amyotrophic lateral sclerosis (ALS)
VOYAGER THERAPEUTICS INC1 citations56
US10983110B2Apr 20, 2021
Assays for the detection of AAV neutralizing antibodies
VOYAGER THERAPEUTICS INC0 citations54
US12291565B2May 6, 2025
Tau binding compounds
VOYAGER THERAPEUTICS INC0 citations38
SAH DINAH WEN-YEE
10 patentsUS8168775B2May 1, 2012
Compositions and methods for inhibiting expression of transthyretin
SAH DINAH WEN-YEE84 citations98
US8741866B2Jun 3, 2014
Compositions and methods for inhibiting expression of transthyretin
SAH DINAH WEN-YEE29 citations92
US9101643B2Aug 11, 2015
Lipid formulated compositions and methods for inhibiting expression of transthyretin (TTR)
SAH DINAH WEN-YEE14 citations84
US8642732B2Feb 4, 2014
Polymer-conjugated glycosylated neublastin
SAH DINAH WEN-YEE2 citations62
US8163875B2Apr 24, 2012
Polymer conjugated glycosylated neublastin
SAH DINAH WEN-YEE2 citations62
US8080532B2Dec 20, 2011
Compositions and methods for inhibiting expression of Huntingtin gene
SAH DINAH WEN-YEE2 citations62
US8119114B2Feb 21, 2012
Polymer conjugates of mutated neublastin
SAH DINAH WEN-YEE3 citations60
US9029525B2May 12, 2015
Compositions and methods for inhibiting expression of GSK-3 genes
SAH DINAH WEN-YEE0 citations52
US8314075B2Nov 20, 2012
Compositions and methods for inhibiting expression of huntingtin gene
SAH DINAH WEN-YEE0 citations52
US8592570B2Nov 26, 2013
Compositions and methods for inhibiting expression of an RNA from West Nile virus
SAH DINAH WEN-YEE0 citations51
ALNYLAM PHARMACEUTICALS INC
7 patentsUS7749978B2Jul 6, 2010
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC113 citations99
US7320965B2Jan 22, 2008
Compositions and methods for inhibiting expression of Huntingtin gene
ALNYLAM PHARMACEUTICALS INC208 citations99
US9234196B2Jan 12, 2016
Compositions and methods for inhibiting expression of transthyretin
ALNYLAM PHARMACEUTICALS INC18 citations92
US10240152B2Mar 26, 2019
Compositions and methods for inhibiting expression of transthyretin
ALNYLAM PHARMACEUTICALS INC6 citations83
US12227744B2Feb 18, 2025
Compositions and methods for inhibiting expression of transthyretin
ALNYLAM PHARMACEUTICALS INC0 citations62
US7902168B2Mar 8, 2011
Compositions and methods for inhibiting expression of Nav1.8 gene
ALNYLAM PHARMACEUTICALS INC1 citations52
US9200282B2Dec 1, 2015
Compositions and methods for inhibiting expression of an RNA from west nile virus
ALNYLAM PHARMACEUTICALS INC0 citations51